# Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

> **NCT01731119** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 9 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorder
- Psychosis NOS
- Autistic Disorder
- Asperger Syndrome
- Child Development Disorders, Pervasive
- Bipolar I Disorder
- Bipolar II Disorder
- Mood Disorder NOS
- Severe Major Depression With Psychotic Features
- Single Episode Major Depression Without Psychotic Symptoms
- Severe Mood Disorder With Psychotic Features

## Interventions

- **DRUG:** Latuda©

## Key facts

- **NCT ID:** NCT01731119
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01731119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01731119, "Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01731119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*